Protein engineering companies design and modify proteins to improve their activity, stability, selectivity and suitability for specific applications. These technologies support therapeutic development, industrial biotechnology, diagnostics and the creation of improved enzymes and research tools.
This category includes companies working on:
Browse 86 UK protein engineering companies below.
Biophysical platform revealing molecular behaviour for discovery
Apoha is a deep tech company developing a biophysical measurement platform based on nonlinear acoustic wave propagation at liquid interfaces. The platform generates…
TCR-based bispecific therapeutics for cancer and autoimmune disease
T-Therapeutics is a biotechnology company developing T cell receptor-based therapeutics for cancer and autoimmune disease. Using a humanised TCR mouse platform to generate…
Global CDMO for biologics development and manufacture
Lonza is one of the world's largest contract development and manufacturing organisations, providing services across biologics, cell and gene therapy, and small molecules. Its…
Automated drug discovery platform and CRO services
Arctoris is a technology-enabled contract research organisation that provides automated wet-lab biology and data generation services to biotech and pharmaceutical companies. The…
Microbial CRO for natural product discovery and fermentation scale-up
Isomerase is a company providing contract research and development services centred on microbial synthetic biology, with expertise spanning natural product discovery, enzyme…
Oral delivery platform for biologics targeting inflammatory diseases
Intract Pharma is a biotechnology company developing proprietary formulation platforms for the oral delivery of complex biologics including monoclonal antibodies and proteins. The…
Proprietary formulation platform enhancing diabetes and cardiometabolic therapies
Arecor Therapeutics is a biopharmaceutical company developing enhanced formulations of existing therapeutic products for diabetes and cardiometabolic diseases. Its proprietary…
Biparatopic PD-1/VEGFR2 antibody for solid tumour oncology
Ottimo Pharma is a clinical-stage biotechnology company developing biparatopic antibody therapeutics for solid tumour cancers. Its lead programme, Jankistomig, is a first-in-class…
Synthetic gene promoter platform for biologics and cell and gene therapy
SynGenSys is a synthetic biology company developing proprietary libraries of synthetic gene promoters and signal peptides designed to improve the yield, specificity, and…
Ultra-high-throughput biologics discovery platform powered by generative AI
Sortera Bio is a biotechnology company developing an AI-powered platform for the discovery and engineering of biological therapeutics. The Deep Screening platform generates…
Generative AI platform for T cell receptor and antibody therapeutics
Etcembly is a biotech company using generative AI to discover and engineer T cell receptor and antibody therapeutics. The company's platform applies large language models to TCR…
Instruments, reagents, and diagnostics for life science research and clinical laboratories
Bio-Rad Laboratories Limited is the UK subsidiary of Bio-Rad Laboratories, Inc., a global manufacturer of instruments and reagents for life science research and clinical…